| Year |
Citation |
Score |
| 2019 |
Ghobadi A, Miller CA, Li T, O'Laughlin M, Lee YS, Ali M, Westervelt P, DiPersio JF, Wartman L. Shared cell of origin in a patient with Erdheim Chester disease and acute myeloid leukemia. Haematologica. PMID 30923101 DOI: 10.3324/Haematol.2019.217794 |
0.332 |
|
| 2017 |
Lee YS, Liu J, Fricano KA, Webb EM, Toolsie DR, Jones S, Rhoads JA, Vij R, Cashen AF, Abboud CN, Westervelt P, Bartlett NL, Dipersio JF, Kreisel FH, Lim KH. Lack of Prognostic Impact of MyD88 L265P Mutation for DLBCL Patients Undergoing Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 28847710 DOI: 10.1016/J.Bbmt.2017.08.022 |
0.304 |
|
| 2016 |
Romee R, Rosario M, Berrien-Elliott MM, Wagner JA, Jewell BA, Schappe T, Leong JW, Abdel-Latif S, Schneider SE, Willey S, Neal CC, Yu L, Oh ST, Lee YS, Mulder A, et al. Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia. Science Translational Medicine. 8: 357ra123. PMID 27655849 DOI: 10.1126/Scitranslmed.Aaf2341 |
0.319 |
|
| 2016 |
Luo H, Schmidt JA, Lee YS, Oltz EM, Payton JE. Targeted epigenetic repression of a lymphoma oncogene by sequence-specific histone modifiers induces apoptosis in DLBCL. Leukemia & Lymphoma. 1-12. PMID 27268204 DOI: 10.1080/10428194.2016.1190973 |
0.413 |
|
| 2008 |
Lee YS, Lim KH, Guo X, Kawaguchi Y, Gao Y, Barrientos T, Ordentlich P, Wang XF, Counter CM, Yao TP. The cytoplasmic deacetylase HDAC6 is required for efficient oncogenic tumorigenesis. Cancer Research. 68: 7561-9. PMID 18794144 DOI: 10.1158/0008-5472.Can-08-0188 |
0.595 |
|
| 2007 |
Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, Yao TP. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Molecular and Cellular Biology. 27: 8637-47. PMID 17938201 DOI: 10.1128/Mcb.00393-07 |
0.33 |
|
| Show low-probability matches. |